Kenneth J. Kelley, Director at HALOZYME THERAPEUTICS, INC. (HALO), sold 31,792 shares at $41.00 ($1.3M) on 2020-12-02, disclosed to the SEC on 2020-12-02.
Open-market sale of $1.3M HALO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| HALO | SELL | 2021-02-01 | $469K | — | Filing → |
| HALO | SELL | 2021-01-04 | $417K | — | Filing → |
| HALO | SELL | 2020-12-07 | $1.4M | — | Filing → |